Participants 75 122 7
children and adolescents with autistic disorder
Participants 276 324 7
children and adolescents with autistic disorders
Participants 394 494 4
patients (5-17 years of age, who completed the previous fixed-dose, 6 week, double-blind [DB] phase)
Participants 779 840 5
S Fifty-six (71%) out of 79 enrolled patients completed the O
